1.
The polymorphisms of T cell–specific TBX21 and STAT4 genes may contribute to the susceptibility of Chinese individuals to aplastic anemia
by Ge, Meili
Human Immunology, 2012, Vol.73(1), pp.118-121
2.
3.
Outcomes of optimized over standard protocol of rabbit antithymocyte globulin for severe aplastic anemia: a single-center experience.
by Li, Xingxin
PloS one, 2013, Vol.8(3), p.e56648
4.
Differential expression profile of Th1/Th17/Th2-related chemokines and their receptors in patients with acquired bone marrow failure syndromes
by Ge, Meili
Human Immunology, February 2013, Vol.74(2), pp.176-180
5.
Clinical features and prognostic factors of Asian patients with paroxysmal nocturnal hemoglobinuria: results from a single center in China
by Ge, Meili
Annals of Hematology, 2012, Vol.91(7), pp.1121-1128
6.
Impaired Autophagy in Adult Bone Marrow CD34+ Cells of Patients with Aplastic Anemia: Possible Pathogenic Significance.
by Huang, Jinbo
PloS one, 2016, Vol.11(3), p.e0149586
7.
TRAF1/C5 rs10818488 polymorphism is not a genetic risk factor for acquired aplastic anemia in a Chinese population
by Ge, Meili
Human Immunology, January 2015, Vol.76(1), pp.19-21
8.
Clinical Features and Survival of Asian Pediatric Patients with Paroxysmal Nocturnal Hemoglobinuria: Results from a Single Center in China
by Ge, Meili
Acta Haematologica, June 2015, Vol.134(1), pp.1-6
9.
Basal level of Th17 immune response is not enhanced in aplastic amemia
by Zhang, Jizhou
Cytokine, August 2015, Vol.74(2), pp.331-334
10.
Long-term follow-up of clonal evolutions in 802 aplastic anemia patients: a single-center experience.
by Li, Yingmei
Annals of hematology, May 2011, Vol.90(5), pp.529-537
11.
Long-term follow-up of clonal evolutions in 802 aplastic anemia patients: a single-center experience
by Li, Yingmei
Annals of Hematology, 2011, Vol.90(5), pp.529-537
12.
Involvement of interleukin‐21 in the pathophysiology of aplastic anemia
by Zhang, Jizhou
European Journal of Haematology, July 2015, Vol.95(1), pp.44-51
13.
Cyclosporin combined with levamisole for refractory or relapsed severe aplastic anaemia
by Shao, Yingqi
British Journal of Haematology, August 2013, Vol.162(4), pp.552-555
14.
Intrinsic impairment of CD4(+)CD25(+) regulatory T cells in acquired aplastic anemia.
by Shi, Jun
Blood, August 23, 2012, Vol.120(8), pp.1624-1632
15.
Cyclosporine Combined with Levamisole for Lower-Risk Myelodysplastic Syndromes
by Li, Xingxin
Acta Haematologica, September 2015, Vol.134(3), pp.138-145
16.
Outcome of a novel immunosuppressive strategy of cyclosporine, levamisole and danazol for severe aplastic anemia
by Wang, Min
International Journal of Hematology, 2015, Vol.102(2), pp.149-156
17.
Clinical profile of megaloblastic anemia in China: a single center experience from MegA-1710 program over two decades
by Huang, Zhendong
Annals of Hematology, 2016, Vol.95(5), pp.827-828
18.
The polymorphisms of T cell-specific TBX21 gene may contribute to the susceptibility of chronic immune thrombocytopenia in Chinese population
by Zhang, Donglei
Human Immunology, February 2014, Vol.75(2), pp.129-133
19.
A promising immunosuppressive strategy of cyclosporine alternately combined with levamisole is highly effective for moderate aplastic anemia
by Li, Xingxin
Annals of Hematology, 2013, Vol.92(9), pp.1239-1247
20.
The polymorphisms of human leukocyte antigen loci may contribute to the susceptibility and severity of severe aplastic anemia in Chinese patients
by Wang, Min
Human Immunology, August 2014, Vol.75(8), pp.867-872
